IntrinsicIntrinsic
← Scroll for more →

Financial Statements — EXYN

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q1 2025Q4 2024Q4 2023
Cash & Equivalents4.497.390.810.461.984.93
Accounts Receivable0.850.571.46--1.73--
Inventory1.711.501.62--1.60--
Total Current Assets11.224.535.14--5.65--
Property, Plant & Equipment0.230.280.34--0.61--
Total Non-current Assets*0.530.620.72--1.14--
Total Assets11.765.155.86--6.79--
Accounts Payable1.182.001.62--1.04--
Total Current Liabilities6.1018.6017.00--6.39--
Long-term Debt1.698.066.12--3.46--
Total Non-current Liabilities0.080.880.17--0.32--
Total Liabilities6.1819.4717.17--6.71--
Retained Earnings(86.05)(79.15)(75.91)--(63.72)--
Total Stockholder Equity5.57(14.32)(11.31)(2.30)0.087.01
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q1 2025
Total Revenue0.951.191.22
Cost of Revenue0.500.690.78
Gross Profit0.450.500.43
Research & Development1.361.211.33
Selling, General & Admin3.021.961.41
Total Operating Expenses4.573.382.95
Operating Income(4.13)(2.87)(2.51)
Pretax Income(6.89)(3.24)(2.58)
Net Income(6.89)(3.24)(2.58)
Basic EPS(1.55)(2.45)(2.74)
Diluted EPS(1.55)(2.45)(2.74)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q1 2025
Operating Cash Flow(5.45)(1.63)(1.51)
Capital Expenditures0.030.000.01
Free Cash Flow*(5.47)(1.63)(1.52)
Investing Cash Flow(0.03)-0.00(0.01)
Financing Cash Flow12.211.92--
← Scroll for more columns →

* Derived from reported values